The Bahamas has become the 12th country or territory in the Americas to receive World Health Organization certification for eliminating mother-to-child transmission of HIV — a milestone that means children in the island nation are now born free of the virus by design, not by chance.
At a glance
- WHO certification: The Bahamas met the global standard requiring a mother-to-child HIV transmission rate below 2% and an incidence below 0.3 per 1,000 live births, sustained over time.
- Universal antenatal care: All pregnant women in The Bahamas receive HIV screening at their first prenatal appointment and again in the third trimester — regardless of nationality or legal status.
- EMTCT Plus Initiative: The certification is part of a broader regional effort to eliminate mother-to-child transmission of HIV, syphilis, hepatitis B, and congenital Chagas disease across the Americas by 2030 C.E.
How The Bahamas got here
The achievement did not happen overnight. It was built on a comprehensive public health model that integrates HIV prevention directly into standard maternal care.
The country’s Maternal and Child Health programme coordinates with its National Infectious Disease Programme to ensure that every pregnant woman — not just those flagged as high-risk — receives consistent testing and follow-up. HIV-positive mothers receive antiretroviral medicines through multi-month dispensing, and exposed infants are monitored closely. The government also introduced pre-exposure prophylaxis (PrEP) for pregnant women, a step that goes beyond the minimum certification requirements.
STI treatment and family planning services are offered free of charge. That policy choice — removing cost as a barrier — is central to why the model works across The Bahamas’ scattered archipelago of more than 700 islands.
“A lot of people have been involved in us achieving this great milestone — our nurses in our public health system, our nurses and doctors in our tertiary health-care system, and all of the clinics spread throughout our archipelago,” said Dr. Michael Darville, The Bahamas’ Minister of Health and Wellness.
A regional movement gaining momentum
The Bahamas joins a list that began with Cuba in 2015 C.E. — the first country in the world to receive this certification — and most recently included Brazil in 2025 C.E. More than half of all countries and territories that have achieved elimination globally are now from Latin America and the Caribbean.
That concentration is not coincidental. The Pan American Health Organization’s Elimination Initiative has set a regional target of eliminating more than 30 communicable diseases by 2030 C.E., and mother-to-child HIV transmission is one of its clearest success stories.
“Latin America and the Caribbean has long been a region of progress in this global effort,” said Anurita Bains, Global Associate Director for HIV/AIDS at UNICEF. “Today, more than half of all countries and territories that have achieved elimination are from this region.”
WHO Director-General Dr. Tedros Adhanom Ghebreyesus called it an “outstanding achievement” reflecting years of political commitment and health worker dedication. UNAIDS Executive Director Winnie Byanyima pointed to the underlying logic: “When women can test early in pregnancy, start treatment quickly, and stay in care, every child has a better chance of being born free of HIV.”
What elimination actually means — and what it doesn’t
It’s important to be precise about the word “elimination.” WHO certification does not mean HIV has been eradicated from The Bahamas. Adults still contract the virus, and ongoing treatment and prevention work remains essential. Certification means the transmission pathway from mother to child has been reduced to a statistically negligible level — a narrow but profound victory.
Sustaining that standard also requires continuous effort. Surveillance systems, drug supply chains, and health worker training must all remain intact. Countries can lose certification if standards slip, which is why The Bahamas has committed to ongoing integrated primary care and monitoring even after receiving the designation.
There are also gaps the certification process doesn’t fully capture — including how well services reach migrant women, incarcerated women, or those in the most remote island communities. The Bahamas’ model of nationality-blind antenatal care is a meaningful attempt to address that, but health equity advocates note that implementation quality across dispersed populations is harder to measure than aggregate statistics suggest.
A proof of concept for the world
What The Bahamas demonstrates is that elimination is achievable even in a small island nation with a geographically fragmented health system — conditions that might seem like structural disadvantages. Universal access, integrated care, and consistent political investment were enough to clear the bar.
That proof matters well beyond the Caribbean. Dozens of countries are still working toward elimination, and the Caribbean model offers a scalable template: screen universally, treat promptly, remove financial barriers, and maintain surveillance.
For the children born in The Bahamas today, the practical meaning is simple. They enter the world without a preventable virus their mothers might have passed on. That outcome — achievable, replicable, and now certified — is what the global health system has been building toward for decades.
Read more
For more on this story, see: World Health Organization
For more from Good News for Humankind, see:
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- U.K. cancer death rates down to their lowest level on record
- The Good News for Humankind archive on The Bahamas
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
More Good News
-
Cornell researchers achieve first reversible male birth control in mice
Reversible male birth control just cleared a major hurdle: in a new Cornell study, male mice stopped producing sperm entirely after three weeks of treatment, then bounced back to full fertility within six weeks of stopping. The approach skips hormones altogether, targeting a specific window of sperm development in the testis so libido and other traits stay untouched. Even better, the mice went on to father healthy pups who were themselves fertile. The researchers are now testing new molecular targets and hope to launch a company within two years to move toward human trials. If the science holds up across…
-
Germany finishes 60-year project turning coal mines into a 23-lake district
Germany’s Lusatian Lakeland is now complete — a chain of 23 human-made lakes covering 14,000 hectares where open-cast coal mines once scarred the land between Berlin and Dresden. The final piece, Lake Sedlitz, opened to swimmers and boaters this April, and in June, five of the lakes will be linked by navigable canals into a continuous 5,000-hectare waterway. Engineers spent decades channeling river water into the old craters, securing embankments, and flushing out acid — work that would have taken nature a century. The region now welcomes around 800,000 overnight stays a year, with former miners finding work in hospitality…
-
Brazilian researchers find vitamin D boosts breast cancer chemo by 79%
Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new Brazilian trial in which 43% of women taking a daily supplement saw their tumors disappear completely, compared to 24% on a placebo. Researchers at São Paulo State University gave 80 patients a modest 2,000 IU dose alongside their standard pre-surgery chemo — a level safe enough for everyday use and cheap enough for almost anyone. Most women in the study were vitamin D-deficient to begin with, a pattern common in cancer patients worldwide. If larger trials confirm the finding, it points to something rare and hopeful…
